3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione and Carcinoma 256, Walker

3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione has been researched along with Carcinoma 256, Walker in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hutchison, DJ; Schmid, FA; Stock, CC; Tarnowski, GS	1

Other Studies

1 other study(ies) available for 3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione and Carcinoma 256, Walker

Article	Year
Chemotherapeutic effects of compound 593A (NSC-135758) on mouse leukemias and some transplanted animal tumors. Cancer chemotherapy reports, 1973, Volume: 57, Issue:1 Topics: Alkylating Agents; Animals; Antibiotics, Antineoplastic; Ascites; Carcinoma 256, Walker; Carcinoma, Ehrlich Tumor; Drug Resistance; Leukemia L1210; Leukemia, Experimental; Mercaptopurine; Methotrexate; Mice; Neoplasm Transplantation; Neoplasms, Experimental; Piperazines; Piperidines; Transplantation, Homologous	1973

Article

Year

Chemotherapeutic effects of compound 593A (NSC-135758) on mouse leukemias and some transplanted animal tumors.

Cancer chemotherapy reports, 1973, Volume: 57, Issue:1

Topics: Alkylating Agents; Animals; Antibiotics, Antineoplastic; Ascites; Carcinoma 256, Walker; Carcinoma, Ehrlich Tumor; Drug Resistance; Leukemia L1210; Leukemia, Experimental; Mercaptopurine; Methotrexate; Mice; Neoplasm Transplantation; Neoplasms, Experimental; Piperazines; Piperidines; Transplantation, Homologous

1973